Found 6 matching trials
A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis
PHASE2The purpose of this study is to assess the efficacy and safety of dose regi...
Location
Investigator Site
A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus
PHASE2Primary objective:
To assess the efficacy and safety of different dose reg...
Location
Investigator Site
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis
PHASE2The primary objective of this study is:
\- To assess the efficacy and safe...
Location
Investigator Site
ALX-0061 Phase I Bioavailability Study in Healthy Volunteers
PHASE1The overall aims of the study are:
* To assess the bioavailability of sing...
Location
Multiple Locations
Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients
PHASE1The purpose of this study is to determine whether the ALX-0061, a Nanobody ...
Location
Multiple Locations
An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis
PHASE2This was a multicenter, open-label extension (OLE) Phase II study designed ...
Location
Investigator Site 1